Stada Arzneimittel AG
18 products tracked · names used in filings: Stada Arzneimittel AG, STADA Arzneimittel AG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Ablymico (liraglutide) approved in the EU
Marketing authorisation to STADA Arzneimittel AG; Additional monitoring · source
Liraglutide STADA (liraglutide) approved in the EU
Marketing authorisation to STADA Arzneimittel AG; Additional monitoring · source
Liraglutide STADA (liraglutide): CHMP positive opinion
STADA Arzneimittel AG; Additional monitoring · source
Ablymico (liraglutide): CHMP positive opinion
STADA Arzneimittel AG; Additional monitoring · source
Gotenfia (golimumab) approved in the EU
Marketing authorisation to Stada Arzneimittel AG; Biosimilar, Additional monitoring · source
Gotenfia (golimumab): CHMP positive opinion
Stada Arzneimittel AG; Biosimilar, Additional monitoring · source
Zvogra (denosumab) approved in the EU
Marketing authorisation to Stada Arzneimittel AG; Biosimilar, Additional monitoring · source
Usgena (ustekinumab) approved in the EU
Marketing authorisation to Stada Arzneimittel AG; Biosimilar, Additional monitoring · source
Kefdensis (denosumab) approved in the EU
Marketing authorisation to Stada Arzneimittel AG; Biosimilar, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Cavoley pegfilgrastim | Application withdrawn | |
| 🇪🇺 | Cavoley pegfilgrastim | Application withdrawn | |
| 🇪🇺 | Ablymico liraglutide | Authorised | 2026-07-15 |
| 🇪🇺 | Liraglutide STADA liraglutide | Authorised | 2026-07-15 |
| 🇪🇺 | Gotenfia golimumab | Authorised | 2026-02-10 |
| 🇪🇺 | Kefdensis denosumab | Authorised | 2025-11-17 |
| 🇪🇺 | Zvogra denosumab | Authorised | 2025-11-17 |
| 🇪🇺 | Usgena ustekinumab | Authorised | 2025-11-17 |
| 🇪🇺 | Afiveg aflibercept | Authorised | 2025-08-18 |
| 🇪🇺 | Tosmova (previously Tocilizumab STADA and Tofidence) tocilizumab | Authorised | 2024-06-20 |
| 🇪🇺 | Uzpruvo ustekinumab | Authorised | 2024-01-05 |
| 🇪🇺 | Ximluci ranibizumab | Authorised | 2022-11-09 |
| 🇪🇺 | Kinpeygo budesonide | Authorised | 2022-07-15 |
| 🇪🇺 | Hukyndra adalimumab | Authorised | 2021-11-15 |
| 🇪🇺 | Libmyris adalimumab | Authorised | 2021-11-12 |
| 🇪🇺 | Oyavas bevacizumab | Authorised | 2021-03-26 |
| 🇪🇺 | Movymia teriparatide | Authorised | 2017-01-11 |
| 🇪🇺 | Silapo epoetin zeta | Authorised | 2007-12-18 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.